DiaMedica Therapeutics (DMAC) Times Interest Earned (2018 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Times Interest Earned came in at -$455.74 in Q1 2026, up 94.4% year-on-year from -$234.43 in Q1 2025, and down 130883.57% quarter-over-quarter from -$0.35 in Q4 2025.
DiaMedica Therapeutics (DMAC) Times Interest Earned (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Times Interest Earned history runs 9 years deep, the most recent figure standing at -$455.74 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 94.4% year-over-year to -$455.74 in Q1 2026; TTM through Mar 2026 was -$854.3, a 41.25% increase from a year earlier, with the FY2025 full-year figure at -$0.81, down 3.91% from the prior year.
- Times Interest Earned eased to -$455.74 in Q1 2026 per DMAC's latest filing, from -$0.35 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.35 in Q4 2025 and bottomed at -$8144.0 in Q1 2025.
- The 5-year median for Times Interest Earned is -$6.23 (2023), against an average of -$784.16.
- Across the five-year window, Times Interest Earned slumped 545981.9% in 2022 and soared 98.65% in 2023, its largest moves.
- Year by year, Times Interest Earned stood at -$4.78 in 2022, then plunged by 47.19% to -$7.03 in 2023, then jumped by 88.31% to -$0.82 in 2024, then soared by 57.67% to -$0.35 in 2025, then plunged by 130883.57% to -$455.74 in 2026.
- Per Business Quant, the three latest DMAC Times Interest Earned figures stand at -$455.74 (Q1 2026), -$0.35 (Q4 2025), and -$0.43 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | DiaMedica Therapeutics | 366.87 Mn | 366.87 Mn | - | -455.74 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -455.74 |
| Dec 31, 2025 | -0.35 |
| Sep 30, 2025 | -0.43 |
| Jun 30, 2025 | -2.13 |
| Mar 31, 2025 | -8,144.00 |
| Dec 31, 2024 | -0.82 |
| Sep 30, 2024 | -1.41 |
| Jun 30, 2024 | -5.44 |
| Mar 31, 2024 | -302.16 |
| Dec 31, 2023 | -7.03 |
| Sep 30, 2023 | -11.16 |
| Jun 30, 2023 | -1.27 |
| Mar 31, 2023 | -47.59 |
| Dec 31, 2022 | -4.78 |
| Sep 30, 2022 | -26.29 |
| Mar 31, 2022 | -3,536.00 |
| Dec 31, 2021 | -190.94 |
| Sep 30, 2021 | -13.56 |
| Jun 30, 2021 | -42.59 |
| Mar 31, 2021 | -0.65 |